March 30, 2017 / 8:51 AM / 6 months ago

BRIEF-Shire says ADHD treatment Intuniv receives approval in Japan

March 30 (Reuters) - Shire Plc:

* Intuniv (guanfacine hydrochloride prolonged release), a non-stimulant for the treatment of ADHD, receives approval in Japan Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below